Document Detail


Home administration of misoprostol for early medical abortion in India.
MedLine Citation:
PMID:  19945104     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To assess the efficacy and acceptability of home administration of misoprostol for early medical abortion in Indian family planning clinics. METHODS: In this prospective cohort study, consenting pregnant women (n=599) with amenorrhea of 8 weeks or less seeking termination of pregnancy received 200mg of oral mifepristone followed 48 hours later with 400microg of oral misoprostol, administered either at home or at the clinic. RESULTS: Almost all women (88.4%) chose to take misoprostol home. There was no statistical difference in success rates between home and clinic users (89.0% vs 92.4%, Pearson chi(2)=0.7; P=0.395). Most women in both the home (90.7%) and clinic (92.3%) groups were satisfied or very satisfied with the procedure. CONCLUSION: Home administration of misoprostol is safe and feasible for introduction into medical abortion services in India.
Authors:
Hillary Bracken;
Related Documents :
17484194 - Medication abortion in the private sector in south africa.
10335154 - Women's experiences of preterm labor: a feminist critique.
12289424 - Undesirable medical advertisements (amendment) ordinance (no. 65 of 1988), 14 july 1988.
19432614 - Choosing medical or surgical terminations of pregnancy in the first trimester: what is ...
6233094 - Acne: an approach to therapy for the pediatrician.
12710844 - Acute aortic syndrome: a case presentation and review of the literature.
Publication Detail:
Type:  Journal Article     Date:  2009-11-27
Journal Detail:
Title:  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics     Volume:  108     ISSN:  1879-3479     ISO Abbreviation:  Int J Gynaecol Obstet     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-02-17     Completed Date:  2010-05-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0210174     Medline TA:  Int J Gynaecol Obstet     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  228-32     Citation Subset:  IM    
Affiliation:
Gynuity Health Projects, New York, NY 10010, USA. hbracken@gynuity.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / administration & dosage*
Adult
Female
Humans
India
Misoprostol / administration & dosage*
Patient Satisfaction
Pregnancy
Prospective Studies
Self Administration
Young Adult
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 59122-46-2/Misoprostol
Investigator
Investigator/Affiliation:
Hillary Bracken / ; Rakhee Babbar / ; Nandita Chandra / ; Suchitra Dalvie / ; Brinda Frey / ; Usha Krishna / ; Aruna A Oza / ; Jnaneshwari Ashok Phadke / ; Shilpa Shroff / ; Suvarna K Vagholkar / ; Maggie Veatch / ; Beverly Winikoff /

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Preliminary uterine artery ligation versus pericervical mechanical tourniquet in reducing hemorrhage...
Next Document:  Cytology versus HPV testing for the detection of high-grade cervical lesions in women found positive...